Francais (Fr)English (United Kingdom)
Recherche
Actualités

Francis Lévi, Warwick Medical School, University of Warwick, July 21, 2014:

- Circadian control of xenobiotic carcinogenesis and cancer pharmacology

- Toward Systems Cancer Chronotherapeutics and its integration into home care 

La Société Francophone de Chronobiologie (SFC) organise son 44ème congrès qui se déroulera du 29-31 octobre 2014

Séance de la Société de Biologie " La chronobiologie " aura lieu le 15 octobre 2014 de 15h00 à 18h00 Institut Curie-Pavillon Curie Amphithéâtre Marie Curie 11, rue Pierre et Marie Curie – Paris 5ème

La soutenance de thèse de Melle Véronique ROCHE sera présentée le 21 mai 2014

Reportage BBC, 13 mai 2014  Chronotherapy: The science of timing drugs to our Body

Journal "Le monde" le 30 avril 2014, "Quand l'horloge biologique se détraque"

 

Voir la suite

Contact

UMRS 935

Equipe3 : Chronothérapie des cancers

et optimisation de la fonction hépatique

INSERM et Université Paris Sud

Bât A 3ème étage Campus CNRS
7 rue Guy Môquet
94801 Villejuif Cedex (France)
Tel :  +33 (0) 1 49 58 34 83
Fax : +33 (0) 1 49 58 34 59
Email:gladys.germe@inserm.fr

Home Production scientifique Publication

2008 

Lévi F. : New chemotherapeutic modalities for primary liver tumors. 4° Simposio Controversie nel trattamento dei tumori epatici. Friday February 1st 2008, Pordenone, Italie (Invité)

C. Ahowesso, XM Li, F Lévi : Caractérisation des classes de chronotoxicité de l’irinotécan chez la Souris. 40ème Congrès de la Société Francophone de Chronobiologie, 4-6 Juin 2008, Caen. (Présentation orale)

Dulong S., Ballesta A., Okyar A., Clairambault J., Lévi F. : Culture de cellules épithéliales coliques humaines et chronopharmacologie de l’irinotécan. 40ème Congrès de la Société Francophone de Chronobiologie, 4-6 Juin 2008, Caen. (Présentation orale)

Weintraub M., Li X.M., Okyar A., Lévi  F. : Effet du schéma d’alimentation programmée sur la physiologie circadienne et la croissance tumorale chez la Souris : influence possible de la lignée ou du sexe. 40ème Congrès de la Société Francophone de Chronobiologie, 4-6 Juin 2008, Caen. (Poster) 

Innominato P.F., Iacobelli S., Piantelli M., Waterhouse J., Bjarnason G., Focan C., Giacchetti S., Poncet A., Garufi C., Lévi F. and the ARTBC Chronotherapy Group : Heterogeneous circadian timing system (CTS) status in cancer patients revealed by complementary assessment of tumor clock proteins and rest-activity rhythm (CircAct). Society for Research on Biological Rhythms 11th Biennial Meeting, May 17th-21st 2008, Sandestin, USA. (Poster)

Li X.M., Filipki E., Innominato P., Claustrat B., Smaaland R., Lévi F. : circadian disruption in host and tumor along experimental cancer progression. Society for Research on Biological Rhythms 11th Biennial Meeting, May 17th-21st 2008, Sandestin, USA. (Poster)

Filipski E., Perumal S., Carrière J., Guettier C., Lévi  F. : Chronic jet lag as hepatocarcinogenesis promoter in mice. Society for Research on Biological Rhythms 11th Biennial Meeting, May 17th-21st 2008, Sandestin, USA. (Poster)

Lévi F. : Personnalized chronotherapeutics of cancer. Proc.The Endocrine Society's 90th Annual Meeting, ENDO 2008, June 15-18 2008, San Francisco, USA, abstr. S 24-3 (Invité)

Iacobelli S., Innominato P., Piantelli M., Bjarnason G., Coudert B., Focan C., Giacchetti S., Poncet A., Garufi C., Levi F. and the ARTBC Chronotherapy Group : Tumor clock protein PER2 as a determinant of survival in patients (pts) receiving oxaliplatin-5-FU-leucovorin as 1st line chemotherapy for metastatic colorectal cancer (MCC). Proc. American Society of Clinical Oncology, 44th Annual Meeting May 30-June 3, 2008, Chicago, Illinois. (Poster discussion)

Lévi F., Parganiha A., Innominato P.F., Karaboué A., Poncet A., Moreau T., Garufi C., Focan C., Coudert B., and Georg B., for the ARTBC Chronotherapy Group. Relevance of circadian coordination for the outcome of cancer patients. Proc. American Society of Clinical Oncology, 44th Annual Meeting May 30-June 3, 2008, Chicago, Illinois.

Bouchahda M., Tabernero J., LIedo G., Levi F., Macarulla T., Karaboue A., Artru P., Castagne V., Bonnet D., Guimbaud R. : Efficacy and safety of cetuximab (C) given with a simplified, every other week, schedule in advanced colorectal cancer (CRC): A multicenter, retrospective study. Proc. American Society of Clinical Oncology, 44th Annual Meeting May 30-June 3, 2008, Chicago, Illinois.

Innominato PF, Iacobelli S, Piantelli M, Waterhouse J, Bjarnason G, Focan C, Giacchetti S, Poncet A, Garufi C,  Lévi F and the ARTBC Chronotherapy Group : Heterogeneous circadian timing system (CTS) status in cancer patients revealed by complementary assessment of tumor clock proteins and rest-activity rhythm (CircAct). Proc. American Society of Clinical Oncology, 44th Annual Meeting May 30-June 3, 2008, Chicago, Illinois.

Lévi F. : Relevance of circadian disruption for cancer processes. ECNIS Workshop (Environmental Cancer, Nutrition and Individual Susceptibility) EEMS 38TH Annual Meeting, September 21-25th 2008, Dubrovnik, Croatia. (Invité) sans Proceedings

Lévi F. : Survey of BioSim’s research in the cancer area. 4th Biosim Conference, September 24-27 th 2008, Budapest, Hongrie. (Oral presentation).

Altinok A., Lévi F. , Goldbeter A. : Using an automaton model for the cell cycle to probe temporal patterns of drug administration in cancer chronotherapy. 4th Biosim Conference, September 24-27 th 2008, Budapest, Hongrie. (Oral presentation).

Clairambault J. : Chronotherapeutic models of combined delivery of anticancer drug 5-fluorouracil and biochemocal modulator leucovorin. 4th Biosim Conference, September 24-27 th 2008, Budapest, Hongrie. (Oral presentation).

Lévi F., Parganiha A., Innominato P.F., Karaboué A., Poncet A., Moreau T., Garufi C., Focan C., Coudert B., and Georg B., for the ARTBC Chronotherapy Group. Relevance of circadian coordination for the outcome of cancer patients. The 6th International Sleep Disorders Forum, September 25-26 2008, Toronto, Canada. (Invité)

Filipski E., Subramanian P., Guettier C., Lévi F. : Chronic jet lag as hepatocarcinogenesis promoter in mice. PROUST Conference (Specific Support Action, 6th European Framework Program) “Gene At Work On Time”, Symposium Satellite “Genes at work on time in cancer processes and their treatments”, October 16-18th 2008, Torino, Italy (Poster)

Okyar A., Dulong S., Filipski E., Ahowesso C., Li X.M., Fernandez S., Delaunay F., Lévi F. : Rhythmic intestinal drug elimination via ABC transporters : a potential determinant of anticancer drugs chronopharmacology. PROUST Conference (Specific Support Action, 6th European Framework Program) “Gene At Work On Time”, Symposium Satellite “Genes at work on time in cancer processes and their treatments”, October 16-18th 2008, Torino, Italy (Poster)

Ballesta A. : Optimizing administration of the anticancer drug irinotecan, taking into account circadian rhythms and acquired resistance, at molecular level. A combined biological and mathematical approach. PROUST Conference (Specific Support Action, 6th European Framework Program) “Gene At Work On Time”, Symposium Satellite “Genes at work on time in cancer processes and their treatments”, October 16-18th 2008, Torino, Italy (Poster)

Clairambault J. : Towards optimization of cancer chronotherapeutics by taking into account patient-specific constraints : mathematical models for individualised medicine. PROUST Conference (Specific Support Action, 6th European Framework Program) “Gene At Work On Time”, Symposium Satellite “Genes at work on time in cancer processes and their treatments”, October 16-18th 2008, Torino, Italy. (Invité)

Innominato P., Lévi F. : Potential circadian biomarkers for tailoring chronotherapeutics. PROUST Conference (Specific Support Action, 6th European Framework Program) “Gene At Work On Time”, Symposium Satellite “Genes at work on time in cancer processes and their treatments”, October 16-18th 2008, Torino, Italy. (Invité)

Parganiha A., Waterhouse J., Karaboué A., Innominato P., Poncet A., Iurisci I., Giacchetti S., Moreau T., Lévi F. : Rest-activity rhythm, a biomarker of the circadian timing system that predicts for toxicity and survival outcomes in cancer patients. PROUST Conference (Specific Support Action, 6th European Framework Program) “Gene At Work On Time”, Symposium Satellite “Genes at work on time in cancer processes and their treatments”, October 16-18th 2008, Torino, Italy. (Présentation orale)

Grassadonia A., Iacobelli S., Innominato P., Piantelli M., Bjarnason G.A., Coudert B., Focan C., Giacchetti S., Poncet A., Garufi C., Lévi F. and the Group of the A.R.T.B.C. Internationale : Tumor clock protein Per2 as a determinant of survival in patients receiving oxaliplatin-5-FU-Leucovorin as first-line chemotherapy for metastatic colorectal cancer. PROUST Conference (Specific Support Action, 6th European Framework Program) “Gene At Work On Time”, Symposium Satellite “Genes at work on time in cancer processes and their treatments”, October 16-18th 2008, Torino, Italy. (Présentation orale)

Lévi F. : Do days and nights matter for lung cancer patients ? 2nd International Respiratory School, 13th-16th November 2008, Dubrovnik, Croatia. (Invité)

Lévi F. : From circadian control of PK/PD to personalized cancer chronotherapeutics. PKUK 2008, 26-28 Novembre 2008, Stansted London, Royaume-Uni. (Invité)

Lévi F. : Circadian clock induction or disruption in cancer therapy. Winter Workshop on parmacokinetics-pharmacodynamics of anticancer drugs : resistances and synergies. Paris, December 18-19 2008. (Invité)

Lévi F. : Le système circadien : déterminant et cible de l’activité des traitements anticancéreux. Académie Nationale de Pharmacie, Paris, 20 Février 2008. (Invité)

<-Retour

 

Mise à jour le : 22/04/2015

Copyright © 2011 ---.
All Rights Reserved